Viral meningitis
- Overview
- Theory
- Diagnosis
- Management
- Follow up
- Resources
Treatment algorithm
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups: see disclaimer
Look out for this icon: for treatment options that are affected, or added, as a result of your patient's comorbidities.
suspected meningitis, unknown aetiology
1st line – empirical antibiotic therapy + manage in line with local protocols
empirical antibiotic therapy + manage in line with local protocols
Always refer a patient with suspected meningitis to hospital for a thorough assessment.[2]McGill F, Heyderman RS, Michael BD, et al. The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults. J Infect. 2016 Apr;72(4):405-38. https://www.journalofinfection.com/article/S0163-4453(16)00024-4/fulltext http://www.ncbi.nlm.nih.gov/pubmed/26845731?tool=bestpractice.com [27]Logan SA, MacMahon E. Viral meningitis. BMJ. 2008 Jan 5;336(7634):36-40. http://www.ncbi.nlm.nih.gov/pubmed/18174598?tool=bestpractice.com
The clinical presentation of viral meningitis is often indistinguishable from that of acute bacterial meningitis.
Start all patients on treatment for bacterial meningitis, including empirical intravenous antibiotics, until the diagnosis of bacterial meningitis is excluded or deemed unlikely. Bacterial meningitis is life-threatening and requires urgent intervention with possible critical care input. See Bacterial meningitis in adults and Bacterial meningitis in children.
Seek advice about initial management of the patient from a senior clinical decision-maker (registrar or consultant) and a microbiologist or infectious diseases consultant.[2]McGill F, Heyderman RS, Michael BD, et al. The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults. J Infect. 2016 Apr;72(4):405-38. https://www.journalofinfection.com/article/S0163-4453(16)00024-4/fulltext http://www.ncbi.nlm.nih.gov/pubmed/26845731?tool=bestpractice.com
Respiratory isolate all patients with suspected meningitis until meningococcal meningitis or meningococcal sepsis is excluded (or considered unlikely) or the patient has had 24 hours of antibiotics.[2]McGill F, Heyderman RS, Michael BD, et al. The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults. J Infect. 2016 Apr;72(4):405-38. https://www.journalofinfection.com/article/S0163-4453(16)00024-4/fulltext http://www.ncbi.nlm.nih.gov/pubmed/26845731?tool=bestpractice.com [38]Meningitis Research Foundation. Early management of suspected meningitis and meningococcal sepsis in immunocompetent adults. January 2016 [internet publication]. https://www.meningitis.org/getmedia/e8ea82ee-e0e9-466d-8526-572108ad6d06/Adult-Protocol-Poster-Nov-2017
Take droplet precautions, including wearing a surgical mask, if likely to be in close contact with respiratory secretions or droplets, until the patient has had 24 hours of antibiotics.[2]McGill F, Heyderman RS, Michael BD, et al. The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults. J Infect. 2016 Apr;72(4):405-38. https://www.journalofinfection.com/article/S0163-4453(16)00024-4/fulltext http://www.ncbi.nlm.nih.gov/pubmed/26845731?tool=bestpractice.com
Practical tip
If cerebrospinal fluid (CSF) testing reveals fungal meningitis, follow your local protocols for management recommendations specific to fungal aetiology. See Fungal meningitis.
Empirical antibiotics
Immediately give empirical antibiotics to all patients with suspected meningitis of unconfirmed aetiology.[2]McGill F, Heyderman RS, Michael BD, et al. The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults. J Infect. 2016 Apr;72(4):405-38. https://www.journalofinfection.com/article/S0163-4453(16)00024-4/fulltext http://www.ncbi.nlm.nih.gov/pubmed/26845731?tool=bestpractice.com [37]National Institute for Health and Care Excellence. Meningitis (bacterial) and meningococcal septicaemia in under 16s: recognition, diagnosis and management. January 2015 [internet publication]. https://www.nice.org.uk/guidance/CG102 [38]Meningitis Research Foundation. Early management of suspected meningitis and meningococcal sepsis in immunocompetent adults. January 2016 [internet publication]. https://www.meningitis.org/getmedia/e8ea82ee-e0e9-466d-8526-572108ad6d06/Adult-Protocol-Poster-Nov-2017 This is because it is difficult to differentiate viral meningitis from bacterial meningitis on clinical grounds alone.
Choose appropriate empirical antibiotics in consultation with an infectious disease consultant/microbiologist.
Use lumbar puncture to confirm a diagnosis of viral meningitis before stopping antibiotics.[38]Meningitis Research Foundation. Early management of suspected meningitis and meningococcal sepsis in immunocompetent adults. January 2016 [internet publication]. https://www.meningitis.org/getmedia/e8ea82ee-e0e9-466d-8526-572108ad6d06/Adult-Protocol-Poster-Nov-2017
If testing identifies a viral pathogen, stop any empirical antibiotics that have been started.[2]McGill F, Heyderman RS, Michael BD, et al. The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults. J Infect. 2016 Apr;72(4):405-38. https://www.journalofinfection.com/article/S0163-4453(16)00024-4/fulltext http://www.ncbi.nlm.nih.gov/pubmed/26845731?tool=bestpractice.com
Supportive care
Give the patient supportive care as needed, including:[2]McGill F, Heyderman RS, Michael BD, et al. The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults. J Infect. 2016 Apr;72(4):405-38. https://www.journalofinfection.com/article/S0163-4453(16)00024-4/fulltext http://www.ncbi.nlm.nih.gov/pubmed/26845731?tool=bestpractice.com
Securing the patient’s airway
Giving oxygen if required
Adequate analgesia/antipyretic
Anti-emetics if the patient is vomiting
Fluid management including intravenous fluids if needed.
Corticosteroids
Typically, adjuvant intravenous dexamethasone is recommended in all previously well and non-immunosuppressed adults and children with suspected meningitis.[2]McGill F, Heyderman RS, Michael BD, et al. The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults. J Infect. 2016 Apr;72(4):405-38. https://www.journalofinfection.com/article/S0163-4453(16)00024-4/fulltext http://www.ncbi.nlm.nih.gov/pubmed/26845731?tool=bestpractice.com [73]Chaudhuri A, Martinez-Martin P, Kennedy PG, et al; EFNS Task Force. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol. 2008 Jul;15(7):649-59. http://www.ncbi.nlm.nih.gov/pubmed/18582342?tool=bestpractice.com Corticosteroids should not be given to patients aged <3 months.[37]National Institute for Health and Care Excellence. Meningitis (bacterial) and meningococcal septicaemia in under 16s: recognition, diagnosis and management. January 2015 [internet publication]. https://www.nice.org.uk/guidance/CG102
Start dexamethasone shortly before or at the same time as antibiotic therapy.[2]McGill F, Heyderman RS, Michael BD, et al. The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults. J Infect. 2016 Apr;72(4):405-38. https://www.journalofinfection.com/article/S0163-4453(16)00024-4/fulltext http://www.ncbi.nlm.nih.gov/pubmed/26845731?tool=bestpractice.com If antibiotics have already been started, dexamethasone may still be given for up to 12 hours after the first dose of antibiotics.[2]McGill F, Heyderman RS, Michael BD, et al. The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults. J Infect. 2016 Apr;72(4):405-38. https://www.journalofinfection.com/article/S0163-4453(16)00024-4/fulltext http://www.ncbi.nlm.nih.gov/pubmed/26845731?tool=bestpractice.com
If testing identifies a viral pathogen, stop any corticosteroids that have been started.[2]McGill F, Heyderman RS, Michael BD, et al. The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults. J Infect. 2016 Apr;72(4):405-38. https://www.journalofinfection.com/article/S0163-4453(16)00024-4/fulltext http://www.ncbi.nlm.nih.gov/pubmed/26845731?tool=bestpractice.com
confirmed viral meningitis
supportive care
If testing identifies a viral pathogen, give the patient supportive care as needed, including:[2]McGill F, Heyderman RS, Michael BD, et al. The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults. J Infect. 2016 Apr;72(4):405-38. https://www.journalofinfection.com/article/S0163-4453(16)00024-4/fulltext http://www.ncbi.nlm.nih.gov/pubmed/26845731?tool=bestpractice.com
Adequate analgesia/antipyretic (e.g., paracetamol, ibuprofen). An opioid (e.g., codeine, morphine) may be required if there is no response to milder analgesics.
Anti-emetics (e.g., ondansetron) if the patient is vomiting.
Fluid management including intravenous fluids if needed.
Stop any empirical antibiotics or corticosteroids that have been started.[2]McGill F, Heyderman RS, Michael BD, et al. The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults. J Infect. 2016 Apr;72(4):405-38. https://www.journalofinfection.com/article/S0163-4453(16)00024-4/fulltext http://www.ncbi.nlm.nih.gov/pubmed/26845731?tool=bestpractice.com
Management is usually conservative. No specific treatment has been proven to be beneficial for viral meningitis.[2]McGill F, Heyderman RS, Michael BD, et al. The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults. J Infect. 2016 Apr;72(4):405-38. https://www.journalofinfection.com/article/S0163-4453(16)00024-4/fulltext http://www.ncbi.nlm.nih.gov/pubmed/26845731?tool=bestpractice.com
Practical tip
Some clinicians treat meningitis confirmed as being caused by herpes simplex, varicella zoster, or cytomegalovirus with antiviral medication, but there is a lack of evidence for the efficacy of these drugs in this setting and they should not be routinely used unless specifically directed by a specialist. Antiviral drugs pose potential risks from side effects and unnecessarily prolonged hospitalisation.[2]McGill F, Heyderman RS, Michael BD, et al. The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults. J Infect. 2016 Apr;72(4):405-38. https://www.journalofinfection.com/article/S0163-4453(16)00024-4/fulltext http://www.ncbi.nlm.nih.gov/pubmed/26845731?tool=bestpractice.com [6]McGill F, Griffiths MJ, Bonnett LJ, et al. Incidence, aetiology, and sequelae of viral meningitis in UK adults: a multicentre prospective observational cohort study. Lancet Infect Dis. 2018 Sep;18(9):992-1003. https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(18)30245-7/fulltext http://www.ncbi.nlm.nih.gov/pubmed/30153934?tool=bestpractice.com
Continue supportive care until the patient is stable. Prioritise the patient’s discharge from hospital if they are well enough.[2]McGill F, Heyderman RS, Michael BD, et al. The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults. J Infect. 2016 Apr;72(4):405-38. https://www.journalofinfection.com/article/S0163-4453(16)00024-4/fulltext http://www.ncbi.nlm.nih.gov/pubmed/26845731?tool=bestpractice.com
Primary options
paracetamol: children: consult specialist for guidance on dose; adults (oral): 500-1000 mg orally every 4-6 hours when required, maximum 4000 mg/day; adults <51 kg body weight (intravenous): 15 mg/kg intravenously every 4-6 hours when required, maximum 60 mg/kg/day; adults ≥51 kg body weight (intravenous): 1000 mg intravenously every 4-6 hours when required, maximum 4000 mg/day (3000 mg/day if risk factors for hepatotoxicity)
or
ibuprofen: children: consult specialist for guidance on dose; adults: 300-600 mg orally (immediate-release) every 6-8 hours when required, maximum 2400 mg/day
-- AND / OR --
ondansetron: children: consult specialist for guidance on dose; adults: 4-8 mg intravenously every 12 hours
More ondansetronHigher doses may be required in some patients; consult local protocols for guidance.
Secondary options
codeine phosphate: 30-60 mg orally every 4 hours when required, maximum 240 mg/day
or
morphine sulfate: 5-10 mg intravenously every 4 hours initially, adjust dose according to response
-- AND / OR --
ondansetron: children: consult specialist for guidance on dose; adults: 4-8 mg intravenously every 12 hours
More ondansetronHigher doses may be required in some patients; consult local protocols for guidance.
These drug options and doses relate to a patient with no comorbidities.
Primary options
paracetamol: children: consult specialist for guidance on dose; adults (oral): 500-1000 mg orally every 4-6 hours when required, maximum 4000 mg/day; adults <51 kg body weight (intravenous): 15 mg/kg intravenously every 4-6 hours when required, maximum 60 mg/kg/day; adults ≥51 kg body weight (intravenous): 1000 mg intravenously every 4-6 hours when required, maximum 4000 mg/day (3000 mg/day if risk factors for hepatotoxicity)
or
ibuprofen: children: consult specialist for guidance on dose; adults: 300-600 mg orally (immediate-release) every 6-8 hours when required, maximum 2400 mg/day
-- AND / OR --
ondansetron: children: consult specialist for guidance on dose; adults: 4-8 mg intravenously every 12 hours
More ondansetronHigher doses may be required in some patients; consult local protocols for guidance.
Secondary options
codeine phosphate: 30-60 mg orally every 4 hours when required, maximum 240 mg/day
or
morphine sulfate: 5-10 mg intravenously every 4 hours initially, adjust dose according to response
-- AND / OR --
ondansetron: children: consult specialist for guidance on dose; adults: 4-8 mg intravenously every 12 hours
More ondansetronHigher doses may be required in some patients; consult local protocols for guidance.
Drug choice, dose and interactions may be affected by the patient's comorbidities. Check your local drug formulary.
Show drug information for a patient with no comorbidities
Primary options
paracetamol
or
ibuprofen
-- AND / OR --
ondansetron
Secondary options
codeine phosphate
or
morphine sulfate
-- AND / OR --
ondansetron
recurrent viral meningitis
1st line – specialist referral for consideration of antiviral therapy
specialist referral for consideration of antiviral therapy
Refer patients with recurrent episodes of confirmed or probable viral meningitis for assessment by an infection or neurological specialist.[2]McGill F, Heyderman RS, Michael BD, et al. The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults. J Infect. 2016 Apr;72(4):405-38. https://www.journalofinfection.com/article/S0163-4453(16)00024-4/fulltext http://www.ncbi.nlm.nih.gov/pubmed/26845731?tool=bestpractice.com
Recurrent benign lymphocytic meningitis (also known as Mollaret's meningitis) is a rare condition thought to be due to viral infection.[2]McGill F, Heyderman RS, Michael BD, et al. The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults. J Infect. 2016 Apr;72(4):405-38. https://www.journalofinfection.com/article/S0163-4453(16)00024-4/fulltext http://www.ncbi.nlm.nih.gov/pubmed/26845731?tool=bestpractice.com Herpes simplex virus (HSV)-2 is most commonly implicated. Aciclovir/valaciclovir should not routinely be given as prophylaxis for recurrent herpes meningitis (HSV or varicella zoster virus).[2]McGill F, Heyderman RS, Michael BD, et al. The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults. J Infect. 2016 Apr;72(4):405-38. https://www.journalofinfection.com/article/S0163-4453(16)00024-4/fulltext http://www.ncbi.nlm.nih.gov/pubmed/26845731?tool=bestpractice.com [74]Aurelius E, Franzen-Röhl E, Glimåker M, et al. Long-term valacyclovir suppressive treatment after herpes simplex virus type 2 meningitis: a double-blind, randomized controlled trial. Clin Infect Dis. 2012 May;54(9):1304-13. http://www.ncbi.nlm.nih.gov/pubmed/22460966?tool=bestpractice.com
A randomised controlled trial of secondary prophylaxis with valaciclovir in patients with either primary or recurrent HSV-2 meningitis found no effect on the risk of recurrence. The study also found an increased risk of recurrence in the valaciclovir group once treatment was stopped.[74]Aurelius E, Franzen-Röhl E, Glimåker M, et al. Long-term valacyclovir suppressive treatment after herpes simplex virus type 2 meningitis: a double-blind, randomized controlled trial. Clin Infect Dis. 2012 May;54(9):1304-13. http://www.ncbi.nlm.nih.gov/pubmed/22460966?tool=bestpractice.com
If a specialist initiates antiviral treatment, this should be stopped after 1 year as Mollaret's meningitis tends to resolve.
Choose a patient group to see our recommendations
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups. See disclaimer
Use of this content is subject to our disclaimer